Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Archive

Proactive news headlines: SourceBio, e-Therapeutics, Greatland Gold and more

First Light Fusion, a company spun out of Oxford University, has achieved nuclear fusion in a world first, independently validated by the UK Atomic Energy Authority.

It is the first time that fusion has been shown to work with a projectile-and-target approach, which the Oxford-based start-up said is simpler, faster and cheaper than traditional fusion methods.

Read more

Roquefort Therapeutics PLC (LSE:ROQ) said Jean Duvall has been appointed as its new independent director, replacing Mark Rollins.

Currently chief executive and co-founder of ReproNovo, a women's health and reproductive medicine company, Duvall is a biotech and pharma sector veteran with over 25 years' experience.

Read more

Greatland Gold PLC (AIM:GGP, OTC:GRLGF) has released the results from its 2021 drilling programme at its 100% owned Scallywag licence.

Seven holes were completed at four prospects, and the company also undertook a ground electro-magnetic survey.

Read more

Ondine Biomedical Inc (AIM:OBI) said independent research confirmed its Steriwave photodisinfection technology is highly effective against human clinical isolates of SARS-CoV-2.

A single dose of photodisinfection can destroy the SARS-CoV-2 viral spike and viral genome, reducing viral load to below detection limit within five minutes, the study found, Ondine said in a statement.

Read more

Faron Pharmaceuticals Oy (AIM:FARN, OTC:FPHAF) has halted a trial of a COVID-19 treatment due to low hospitalisation rates and a shortage of patients that have not already received steroids as part of their remedy.

The Phase II/III HIBISCUS trial was assessing Traumakine (intravenous interferon beta-1a; IFN beta-1a) as a first-line treatment for hospitalised COVID-19 patients who required low flow oxygen support.

Read more

Sovereign Metals Ltd (ASX:SVM, AIM:SVML) hit a record high after delivering a 1.8-billion-tonne resource in an updated mineral resource estimate (MRE), confirming that the Kasiya rutile deposit in Malawi is the world’s largest rutile deposit ever discovered as well as the second-largest flake graphite deposit.

The Kasiya mega-deposit with a grade of 1.01% rutile now hosts 18 million tonnes of contained rutile – tripling from the previous MRE.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK